AM3 inhibits LPS-induced iNOS expression in mice

We have analyzed the effect of a patented glycoconjugate of natural origin, AM3 (commercially available under the name Inmunoferon®) in the expression of iNOS induced by administration of LPS in mice. We have observed that oral treatment with the drug daily for 6 days reduced the levels of expressio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International immunopharmacology 2005-07, Vol.5 (7), p.1165-1170
Hauptverfasser: Majano, Pedro, Alonso-Lebrero, José Luis, Janczyk, Agnieszka, Martín-Vichez, Samuel, Molina-Jiménez, Francisca, Brieva, Aurora, Pivel, Juan Pablo, González, Salvador, López-Cabrera, Manuel, Moreno-Otero, Ricardo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We have analyzed the effect of a patented glycoconjugate of natural origin, AM3 (commercially available under the name Inmunoferon®) in the expression of iNOS induced by administration of LPS in mice. We have observed that oral treatment with the drug daily for 6 days reduced the levels of expression of iNOS induced by an intravenous pulse of LPS. This effect was significant in the lungs and kidneys, but it was much more marked in the liver. In addition, the levels of nitric oxide in serum were clearly decreased upon treatment with AM3. Together, these results suggest that AM3 modulates the nitric oxide response and points to a possible role for AM3 in the control of the inflammatory response.
ISSN:1567-5769
1878-1705
DOI:10.1016/j.intimp.2005.02.009